Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
The White House said Friday it was "dangerous and unacceptable" for elected officials to target women's access to federally-approved abortion pills.
Read Full NewsNew York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.
The drug was previously approved for stage 2 T1D.
Findings suggest young females should be assessed and, if at risk, monitored.
Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.
Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.
The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.
Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having been submitted for regulatory approval.
1.
Study: For predicting breast cancer, AI performs better than traditional risk models.
2.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
3.
In Advanced Myxoid Liposarcoma, Is Trabectedin Winning?
4.
Study finds that AI is better at forecasting the risk of developing cancer.
5.
Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit
1.
Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion
2.
Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies
3.
Everything You Need to Know About Leiomyomas: A Comprehensive Guide
4.
Hemophilia: Pathophysiology, Genetics, and Treatment Advances
5.
Emerging Trends in Oncology for Modern Medicine
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Navigating the Complexities of Ph Negative ALL - Part XIV
2.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge